ConductScience.org, home

Paper1011990

Fibrin-stabilizing factor (factor XIII).

Curtis CG and 1 other. Methods Enzymol, 1976. Cited by 58 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Fibrin-stabilizing factor (factor XIII). Papers, record 1011990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1011990

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fibrin-stabilizing factor (factor XIII).
PubMed
Journal
Methods Enzymol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
1.7
iCite
Revised in PubMed
2019-07-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Curtis CGC G
2Lorand LL

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Factor XIIIMajor topic
Animals
Cations, Divalent
Enzyme Activation
Fibrin
Fluorescent Dyes
Macromolecular Substances
Methods
Molecular Weight
Spectrometry, Fluorescence

Source PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
10,377,424Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10377424PubMed
7,430,249Fibronectin-mediated uptake of gelatin-coated latex particles by peritoneal macrophages.J Cell Biol1980https://conductscience.org/library/papers/7430249PubMed
7,199,538Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.J Clin Invest1982https://conductscience.org/library/papers/7199538PubMed
6,889,599Ultrastructure of clots during isometric contraction.J Cell Biol1982https://conductscience.org/library/papers/6889599PubMed
6,886,002"Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.J Clin Invest1983https://conductscience.org/library/papers/6886002PubMed
6,853,717Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen.J Clin Invest1983https://conductscience.org/library/papers/6853717PubMed
6,376,109Biochemical and cellular mechanisms of dust-induced lung fibrosis.Environ Health Perspect1984https://conductscience.org/library/papers/6376109PubMed
6,143,256Transglutaminases.Mol Cell Biochem1984https://conductscience.org/library/papers/6143256PubMed
3,422,419Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3422419PubMed
2,888,718Isolation of a polymorphic genomic clone from chromosome 7. Physical and genetic linkage studies to markers around the cystic fibrosis locus.Hum Genet1987https://conductscience.org/library/papers/2888718PubMed
2,877,457Characterization of cDNA coding for human factor XIIIa.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/2877457PubMed
2,860,124Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.J Clin Invest1985https://conductscience.org/library/papers/2860124PubMed
2,440,424The conformational changes of alpha 2-macroglobulin induced by methylamine or trypsin. Characterization by extrinsic and intrinsic spectroscopic probes.Biochem J1987https://conductscience.org/library/papers/2440424PubMed
2,419,360Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.J Clin Invest1986https://conductscience.org/library/papers/2419360PubMed
1,978,326Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/1978326PubMed
279,911Ca2+-related regulatory function of fibrinogen.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/279911PubMed
96,136Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.J Clin Invest1978https://conductscience.org/library/papers/96136PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
F13A12,162PubTator's text mininghttps://conductscience.org/library/genes/2162

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1011990

GET https://conductscience.org/api/papers/v1/1011990/authors